Back to Jobs
Definium Therapeutics
Finance & Accounting 13h ago

Senior Director, Commercial Finance

Definium Therapeutics
United StatesUnited States
Full-time
$220,000.00-$270,000.00
Senior-Level

Job Description

Key Skills Required

Master these to land this role

Data Analyst2h 18mFree Trial ✨
Start 10-Day Free Trial
QuickBooks39 HoursFree Trial ✨
Start 10-Day Free Trial
CFOBusiness IntelligenceFinancial Analyst

Want to know if you're a match for this job?

Calculate My Match Score

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!

We are seeking an experienced and highly strategic Senior Director, Commercial Finance to lead the Commercial Finance function. This individual will serve as a key business partner to the Commercial Leadership team, providing financial leadership and decision support as the company evolves toward commercialization. The ideal candidate combines deep pharmaceutical or biotechnology commercial finance experience with the ability to operate effectively in a fast-paced, resource-conscious environment. This role will help establish the commercial finance infrastructure, processes, forecasting methodologies, performance metrics, and strategic decision-making capabilities needed to support a high-growth organization. Reporting to the VP, Finance & Strategy, the Senior Director will play a critical leadership role in long-range planning, revenue forecasting, launch readiness, resource allocation, and business performance management.

Responsibilities

  • Serve as the primary finance business partner to Commercial leadership, providing strategic financial guidance and decision support
  • Lead commercial financial planning processes, including annual budgets, quarterly forecasts, long-range planning, and scenario analysis.
  • Develop and maintain revenue forecasts, demand models, and commercial planning assumptions, partnering with Commercial Accounting on gross-to-net methodologies and financial implications of pricing, reimbursement, and market access strategies
  • Partner with Commercial leadership to assess commercial readiness, evaluate infrastructure and investment priorities, and support sales force sizing, territory planning, and resource optimization
  • Support product strategy, commercialization planning, and strategic initiatives through financial modeling, business case development, ROI analysis, competitive assessments, and market opportunity evaluations
  • Develop KPIs, dashboards, and reporting tools to track launch preparedness and commercial performance, providing actionable insights to support decision-making
  • Prepare analyses and presentations for Executive Leadership, Board meetings, and strategic planning discussions
  • Establish and scale the commercial finance function, including processes, systems, and best practices to support business growth
  • Partner with the broader FP&A organization to ensure alignment and consistency across corporate planning activities

Qualifications

  • Bachelor's degree in Finance, Accounting, Economics, Business, or a related field; MBA, CPA, or CFA preferred
  • Minimum 10 years of progressive finance experience, including significant FP&A and commercial finance leadership experience
  • Experience supporting commercial organizations within the pharmaceutical, biotechnology, or life sciences industries
  • Experience supporting commercial readiness activities, product launches, revenue forecasting, and market access planning
  • Strong understanding of pharmaceutical commercialization, pricing, reimbursement, and gross-to-net forecasting
  • Advanced financial modeling, forecasting, and analytical skills
  • Proven ability to influence cross-functional stakeholders and communicate effectively with senior leadership
  • Experience working in high-growth, dynamic environments with evolving business needs

The starting base pay range for this position is $220,000.00-$270,000.00. Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee’s geographic location.

Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including:

  • 100% paid health benefits including Medical, Dental and Vision for you and your dependents
  • 401(k) program with company match and vesting after the turn of the first month after your start date
  • Flexible time off
  • Generous parental leave and some fun fringe perks!

How would you rate this job post?

See what other professionals think about this role.

banner
logo

Definium Therapeutics

View Company Profile

Definium Therapeutics (operating at definiumtx.com) is a clinical biopharmaceutical company engineered for developing novel product candidates to treat brain health disorders. Founded in 2019 by Jamon "JR" Rahn, Stephen Hurst, and Scott Freeman and headquartered in New York, Definium Therapeutics is forging a new era in psychiatry by harnessing the full therapeutic potential of psychedelic medicine. Under the hood, the company is applying precision to psychedelic medicine. This allows researchers and patients to explore new treatment options for brain health disorders. Backed by a $259 million equity financing in 4Q 2025.

Safety First

  • Never pay for a job application.
  • Do not share sensitive bank info.
  • Verify the client before starting work.
Learn More